CVE-2015-3965

MITRE NVD CVE.ORG JSON API Print: PDF PDF

Summary

CVECVE-2015-3965
StatePUBLIC
Assigner[email protected]
Source PriorityCVE Program / NVD first with legacy fallback
Published2019-03-23 20:29:00 UTC
Updated2019-03-25 19:06:00 UTC
DescriptionHospira Symbiq Infusion System 3.13 and earlier allows remote authenticated users to trigger "unanticipated operations" by leveraging "elevated privileges" for an unspecified call to an incorrectly exposed function.

Risk And Classification

Problem Types: CWE-264

NVD Known Affected Configurations (CPE 2.3)

TypeVendorProductVersionUpdateEditionLanguage
Hardware Pfizer Symbiq Infusion System - All All All
Hardware Pfizer Symbiq Infusion System - All All All
Operating System Pfizer Symbiq Infusion System Firmware All All All All

References

ReferenceSourceLinkTags
Hospira Symbiq Infusion System Vulnerability | CISA MISC ics-cert.us-cert.gov Third Party Advisory, US Government Resource
CVE Program record CVE.ORG www.cve.org canonical
NVD vulnerability detail NVD nvd.nist.gov canonical, analysis

© CVE.report 2026

Use of this information constitutes acceptance for use in an AS IS condition. There are NO warranties, implied or otherwise, with regard to this information or its use. Any use of this information is at the user's risk. It is the responsibility of user to evaluate the accuracy, completeness or usefulness of any information, opinion, advice or other content. EACH USER WILL BE SOLELY RESPONSIBLE FOR ANY consequences of his or her direct or indirect use of this web site. ALL WARRANTIES OF ANY KIND ARE EXPRESSLY DISCLAIMED. This site will NOT BE LIABLE FOR ANY DIRECT, INDIRECT or any other kind of loss.

CVE, CWE, and OVAL are registred trademarks of The MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. This site includes MITRE data granted under the following license.

Free CVE JSON API cve.report/api

CVE.report and Source URL Uptime Status status.cve.report